My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 172

    1.

    Intracerebroventricular neuropeptide Y infusion precludes inhibition of glucose and VLDL production by insulin.

    van den Hoek AM, Voshol PJ, Karnekamp BN, Buijs RM, Romijn JA, Havekes LM, Pijl H.

    Diabetes. 2004 Oct;53(10):2529-34.PMID: 15448080 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Intracerebroventricular administration of neuropeptide Y induces hepatic insulin resistance via sympathetic innervation.

    van den Hoek AM, van Heijningen C, Schröder-van der Elst JP, Ouwens DM, Havekes LM, Romijn JA, Kalsbeek A, Pijl H.

    Diabetes. 2008 Sep;57(9):2304-10. Epub 2008 Jun 10.PMID: 18544708 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    PYY3-36 reinforces insulin action on glucose disposal in mice fed a high-fat diet.

    van den Hoek AM, Heijboer AC, Corssmit EP, Voshol PJ, Romijn JA, Havekes LM, Pijl H.

    Diabetes. 2004 Aug;53(8):1949-52.PMID: 15277371 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Intracerebroventricular neuropeptide Y acutely influences glucose metabolism and insulin sensitivity in the rat.

    Marks JL, Waite K.

    J Neuroendocrinol. 1997 Feb;9(2):99-103.PMID: 9041362 [PubMed - indexed for MEDLINE]Related articles

    5.

    Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats.

    Vettor R, Zarjevski N, Cusin I, Rohner-Jeanrenaud F, Jeanrenaud B.

    Diabetologia. 1994 Dec;37(12):1202-8.PMID: 7895949 [PubMed - indexed for MEDLINE]Related articles

    6.

    Chronic central melanocortin-4 receptor antagonism and central neuropeptide-Y infusion in rats produce increased adiposity by divergent pathways.

    Baran K, Preston E, Wilks D, Cooney GJ, Kraegen EW, Sainsbury A.

    Diabetes. 2002 Jan;51(1):152-8.PMID: 11756335 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Intracerebroventricular administration of neuropeptide Y to normal rats has divergent effects on glucose utilization by adipose tissue and skeletal muscle.

    Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, Jeanrenaud B.

    Diabetes. 1994 Jun;43(6):764-9.PMID: 8194661 [PubMed - indexed for MEDLINE]Related articles

    8.

    Intracerebroventricular administration of neuropeptide Y to normal rats increases obese gene expression in white adipose tissue.

    Sainsbury A, Cusin I, Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B.

    Diabetologia. 1996 Mar;39(3):353-6.PMID: 8721783 [PubMed - indexed for MEDLINE]Related articles

    9.

    Intraportal administration of neuropeptide Y and hepatic glucose metabolism.

    Nishizawa M, Shiota M, Moore MC, Gustavson SM, Neal DW, Cherrington AD.

    Am J Physiol Regul Integr Comp Physiol. 2008 Apr;294(4):R1197-204. Epub 2008 Jan 30.PMID: 18234742 [PubMed - indexed for MEDLINE]Related articles

    10.

    Hepatic glucose production is more sensitive to insulin-mediated inhibition than hepatic VLDL-triglyceride production.

    den Boer MA, Voshol PJ, Kuipers F, Romijn JA, Havekes LM.

    Am J Physiol Endocrinol Metab. 2006 Dec;291(6):E1360-4. Epub 2006 Jul 18.PMID: 16849628 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Effects of intravenous neuropeptide Y on insulin secretion and insulin sensitivity in skeletal muscle in normal rats.

    Vettor R, Pagano C, Granzotto M, Englaro P, Angeli P, Blum WF, Federspil G, Rohner-Jeanrenaud F, Jeanrenaud B.

    Diabetologia. 1998 Nov;41(11):1361-7.PMID: 9833945 [PubMed - indexed for MEDLINE]Related articles

    12.

    Interaction between adrenal glucocorticoids and parasympathetic activation in mediating hyperinsulinaemia during long-term central neuropeptide Y infusion in rats.

    Sainsbury A, Wilks D, Cooney GJ.

    Diabetologia. 2000 Jul;43(7):859-65.PMID: 10952458 [PubMed - indexed for MEDLINE]Related articles

    13.

    CNTO736, a novel glucagon-like peptide-1 receptor agonist, ameliorates insulin resistance and inhibits very low-density lipoprotein production in high-fat-fed mice.

    Parlevliet ET, Schröder-van der Elst JP, Corssmit EP, Picha K, O'Neil K, Stojanovic-Susulic V, Ort T, Havekes LM, Romijn JA, Pijl H.

    J Pharmacol Exp Ther. 2009 Jan;328(1):240-8. Epub 2008 Oct 10.PMID: 18849357 [PubMed - indexed for MEDLINE]Related articles

    14.

    Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites.

    Lam TK, van de Werve G, Giacca A.

    Am J Physiol Endocrinol Metab. 2003 Feb;284(2):E281-90.PMID: 12531742 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Intracerebroventricular leptin regulates hepatic but not peripheral glucose fluxes.

    Liu L, Karkanias GB, Morales JC, Hawkins M, Barzilai N, Wang J, Rossetti L.

    J Biol Chem. 1998 Nov 20;273(47):31160-7.PMID: 9813020 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Metabolic and orexigenic effects of intracerebroventricular neuropeptide Y are attenuated by food deprivation.

    Parikh R, Marks JL.

    J Neuroendocrinol. 1997 Oct;9(10):789-95.PMID: 9355048 [PubMed - indexed for MEDLINE]Related articles

    17.

    Some acute effects of intracerebroventricular neuropeptide Y on insulin secretion and glucose metabolism in the rat.

    Marks JL, Waite K.

    J Neuroendocrinol. 1996 Jul;8(7):507-13.PMID: 8843019 [PubMed - indexed for MEDLINE]Related articles

    18.

    Oxyntomodulin ameliorates glucose intolerance in mice fed a high-fat diet.

    Parlevliet ET, Heijboer AC, Schröder-van der Elst JP, Havekes LM, Romijn JA, Pijl H, Corssmit EP.

    Am J Physiol Endocrinol Metab. 2008 Jan;294(1):E142-7. Epub 2007 Oct 30.PMID: 17971509 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Intracerebroventricular administration of melanotan II increases insulin sensitivity of glucose disposal in mice.

    Heijboer AC, van den Hoek AM, Pijl H, Voshol PJ, Havekes LM, Romijn JA, Corssmit EP.

    Diabetologia. 2005 Aug;48(8):1621-6. Epub 2005 Jun 22.PMID: 15971058 [PubMed - indexed for MEDLINE]Related articles

    20.

    Inhibitory effects of neuropeptide Y on splanchnic glycogenolysis and renin release in humans.

    Ahlborg G, Lundberg JM.

    Clin Physiol. 1994 Mar;14(2):187-96.PMID: 8205750 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity